Location History:
- Mountain View, CA (US) (2012)
- Menlo Park, CA (US) (2018 - 2023)
Company Filing History:
1 out of 1 
1 out of 35 
1 out of 1 Years Active: 2012-2023
Title: Steven Albert Everett: Innovator in Pharmaceutical Chemistry
Introduction
Steven Albert Everett is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical therapy. With a total of 3 patents, his work focuses on innovative solutions for treating proliferative conditions, including various forms of cancer.
Latest Patents
Everett's latest patents include groundbreaking research on small molecule drug conjugates of gemcitabine monophosphate. This patent discloses compounds that can be utilized in pharmaceutical applications, including their compositions and methods of use. Another significant patent addresses the treatment or prophylaxis of proliferative conditions, specifically targeting cells that express cytochrome P450 1B1 (CYP1B1). This invention not only provides pharmaceutical compositions for medical therapy but also outlines methods for identifying novel compounds and determining their efficacy in treating cancer.
Career Highlights
Throughout his career, Steven Albert Everett has worked with prestigious institutions, including the University of Dundee. His research has contributed to advancements in the understanding and treatment of cancer and other proliferative conditions. His innovative approach to drug development has positioned him as a key figure in pharmaceutical research.
Collaborations
Everett has collaborated with notable colleagues such as Saraj Ulhaq and Craig Alan Coburn. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the field of pharmaceutical chemistry.
Conclusion
Steven Albert Everett's contributions to pharmaceutical chemistry through his patents and collaborations highlight his commitment to advancing medical therapies. His innovative work continues to pave the way for new treatments in the fight against cancer and other proliferative conditions.